Terms ending in 2029
Every in-force patent on Wyeth, LLC's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,879,828 | Tigecycline Compositions and Methods of Preparation In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,808,707 | Pneumococcal Dosing Regimen In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,895,724 | Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,632,995 | High-Cell Density Fed-Batch Fermentation Process for Producing Recombinant Protein In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,110,705 | Processes for Making Hydrazides In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,039,231 | Methods for Enhanced Production of Bone Morphogenetic Proteins In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,217,036 | Triazine Compounds as PI3 Kinase and Mtor Inhibitors In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,445,486 | Triazine Compounds as PI3 Kinase and Mtor Inhibitors In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,575,159 | Triazine Compounds as PI3 Kinase and Mtor Inhibitors In force · High confidence | Wyeth LLC | In force | High confidence | |
| US 8,748,421 | Triazine Compounds as PI3 Kinase and Mtor Inhibitors In force · High confidence | Wyeth LLC | In force | High confidence | |
| 20 more term ends in 2029 · Pro | |||||
10 of 30 patents shown. Soonest term end first, then patent number.
Pro members see all 30.
27 of these are in force and held by Wyeth, LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.